Tratamiento con sirolimus y prednisona en enfermedad de Erdheim-Chester con compromiso cardiaco: caso clínico / Sirolimus and prednisone for the treatment of Erdheim-Chester disease with cardiac involvement: report of one case
Rev. méd. Chile
;
144(3): 394-400, mar. 2016. ilus, tab
Article
Dans Espagnol
| LILACS
| ID: lil-784911
ABSTRACT
Erdheim-Chester disease (ECD) is a rare non-Langerhans histiocytic disorder. We report a 76-years-old man who suffered a cardiac tamponade secondary to ECD. A pericardial window was made and during the operation the surgeons observed that the myocardium was diffusely infiltrated. Twenty-eight months before, ECD was clinically diagnosed and prednisone and methotrexate were prescribed. Due to disease progression which culminated in the cardiac tamponade, methotrexate was changed to sirolimus aiming to obtain plasma levels between 5-8 ng/ml. This treatment stabilized his cardiac function allowing a survival of 52 months after its initiation, with fewer side effects.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Prednisone
/
Tamponnade cardiaque
/
Sirolimus
/
Maladie d'Erdheim-Chester
/
Anti-inflammatoires
Limites du sujet:
Adulte très âgé
/
Humains
/
Mâle
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
2016
Type:
Article
Pays d'affiliation:
Chili
Institution/Pays d'affiliation:
Hospital Naval A. Nef/CL
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS